Data / Form D filings / LiveLeaf, Inc.
LiveLeaf, Inc.: Form D filings
LiveLeaf, Inc., a biotechnology company in San Carlos, CA, filed 4 Form D notices with the SEC between 2011 and 2015. The latest, on May 18, 2015, reports $2.3 million sold of a $3.5 million offering to 6 investors.
Find out what LiveLeaf, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1160 INDUSTRIAL ROAD, #11, San Carlos, CA, 94070
- Phone
- (877) 925-2888
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1534234
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 18, 2015 | New notice | $3,500,000 | $2,250,000 | $1,250,000 | 6 | Jun 13, 2014 | sec.gov |
| Sep 6, 2013 | Amendment | $12,000,000 | $3,850,000 | $8,150,000 | 8 | Sep 19, 2012 | sec.gov |
| Sep 28, 2012 | New notice | $5,000,000 | $550,000 | $4,450,000 | 1 | Sep 19, 2012 | sec.gov |
| Nov 10, 2011 | New notice | $3,806,742 | $2,597,537 | $1,209,205 | 17 | Oct 28, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Ullman | Director | |
| Gin Wu | Executive Officer, Director | |
| David Chein | Director | |
| Alex Huang | Executive Officer, Director | |
| Chloe Chan | Executive Officer |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of May 18, 2015 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what LiveLeaf, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.